Cardiometabolic Consequences of the Loss of Ovarian Function — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cardiometabolic Consequences of the Loss of Ovarian Function — Stella

Home/Menopause/

View on ClinicalTrials.gov

Recruiting

Back to Menopause trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Colorado Anschutz Medical Campus, Aurora, Colorado

Key details

Phase

Post-approval study

Sponsor

University of Colorado, Denver

Collaborators

National Institute on Aging (NIA)

Enrollment target

~100 participants

Started

June 2024

Primary completion

May 2028

Age range

20 Years – 45 Years

Sex

Female only

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.